Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
844 participants
OBSERVATIONAL
2016-01-15
2017-10-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
endometriosis
Survey on first pregnancy after endometriosis diagnosis
Survey on first pregnancy after endometriosis diagnosis
rate of miscarriage was noted
non endometriosis
Survey on first pregnancy
Survey on first pregnancy
rate of miscarriage was noted
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey on first pregnancy after endometriosis diagnosis
rate of miscarriage was noted
Survey on first pregnancy
rate of miscarriage was noted
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with at least one previous spontaneous pregnancy
* with surgical or clinical/sonographic diagnosis of endometriosis or
* in whom surgical or clinical/sonographic evaluation ruled out endometriosis
Exclusion Criteria
* Biochemical pregnancy
* Non corrected uterine malformation, poliabortivity, lupus like anticoagulant
30 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Milan
OTHER
Endometriosis Treatment Italian Club
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicola Berlanda, MD
Role: PRINCIPAL_INVESTIGATOR
Endometriosis Treatment Italian Club
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ETIC001
Identifier Type: -
Identifier Source: org_study_id